Ethyl 2-(5-bromo-1H-indol-1-yl)propionate, 95.0%, 250mg

3-Bromo-6-methoxy-1H-pyrrolo[3,2-b]pyridine, 97.0%, 100mg

(R)-3-Amino-3-(naphthalen-2-yl)propanoic acid, 95.0%, 1g

1-Isopropyl-3-methyl-6-((5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)methyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidine-5-carboxylic acid, 95%, 100mg

(R)-GAMMA-VALEROLACTONE, 95%, 250mg

2-Chloro-3-(trifluoromethyl)benzyl alcohol, 95.0%, 100mg

2-amino-4-[4-(trifluoromethyl)phenyl]butanoic acid, 95.0%, 500mg

Receptor de vacío con conexión roscada recta, 29/32, 29/32, 1 Pieza

3-BROMO-2-METHYL-1H-PYRROLO[2,3-C]PYRIDINE, 95.0%, 500mg

N-(2,4-dimethoxybenzyl)-2-oxo-N-(thiazol-2-yl)-2,3-dihydrobenzo[d]oxazole-6-sulfonamide, 95%, 1g

2-(4-Iodo-phenoxy)-ethanol, 250mg

(2-(Difluoromethoxy)pyridin-3-yl)boronic acid, 95.0%, 250mg

4-Bromo-3-fluoro-2-methoxy-benzaldehyde, 95%, 500mg